Syndromic Surveillance for E-Cigarette, or Vaping, Product Use-Associated Lung Injury

N Engl J Med. 2020 Feb 20;382(8):766-772. doi: 10.1056/NEJMsr1915313. Epub 2019 Dec 20.

¹ From the Division of Health Informatics and Surveillance, Center for Surveillance, Epidemiology, and Laboratory Services (K.P.H., A.K.-P., B.L.H., M.J.S., T.P.D., Z.S., N.I., L.R., J.A.), the Division of Overdose Prevention, National Center for Injury Prevention and Control (A.M.V.-K.), the Office on Smoking and Health (B.A.K., P.C.M.), Division for Heart Disease and Stroke Prevention (M.D.R.), and the Office of the Director (P.A.B.), National Center for Chronic Disease Prevention and Health Promotion, the Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases (D.A.R.), Centers for Disease Control and Prevention, Atlanta; Illinois Department of Public Health, Springfield (M.T.P., J.E.L.,); and the U.S. Public Health Service Commissioned Corps, Rockville, MD (K.P.H., M.D.R., P.C.M., L.R., J.A.).

No abstract available

MeSH terms